Mohammadreza Babaei: Anticoagulation versus No Anticoagulation after Intracranial Hemorrhage in Patients with Atrial Fibrillation
Amir Ghaffari Jolfayi, Research Assistant at Rajaie Cardiovascular, Medical and Research Institute, quoted Mohammadreza Babaei’s post on LinkedIn:
“Excited to share our latest publication in BMC Cardiovascular Disorders!
Title: Anticoagulation versus no anticoagulation after intracranial hemorrhage in patients with atrial fibrillation: an updated systematic review and meta-analysis
Key findings: This meta-analysis of five randomized controlled trials shows that anticoagulation reduces thromboembolic events in patients with atrial fibrillation after intracranial hemorrhage, but is associated with a notably higher risk of recurrent bleeding. It underscores the need for personalized, patient-specific decision-making to balance these risks and benefits.
Special Thanks to Mohammadreza Babaei and the team!
Read the full article here”
Title: Anticoagulation versus no anticoagulation after intracranial hemorrhage in patients with atrial fibrillation: an updated systematic review and meta-analysis
Authors: Mohammadreza Babaei, Parisa Fallahtafti, Sina Rashedi, Amir Ghaffari Jolfayi, Zahra Hosseini, Kaveh Hosseini, Masih Tajdini, Hamidreza Soleimani
Quoting Mohammadreza Babaei’s post:
“Check out our recently published article in BMC Cardiovascular Disorders, titled:
“Anticoagulation versus no anticoagulation after intracranial hemorrhage in patients with atrial fibrillation: an updated systematic review and meta-analysis”
The results of this meta-analysis of five RCTs suggest that anticoagulation provides clinically meaningful reductions in thromboembolic events, but at the cost of a significantly increased risk of bleeding in this population. These findings indicate the importance of carefully selecting patients on an individual basis when weighing the benefits and risks of therapy.
Many thanks to the team members, Parisa Fallahtafti, Sina Rashedi, and Amir Ghaffari Jolfayi for their dedication, and our professors Hamidreza Soleimani, Zahra Hosseini, Kaveh Hosseini, Masih Tajdini for their support and guidance.”
Discover the latest in Hemostasis Today.
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026
-
Jul 12, 2026, 06:59Maaike Sybil Jongen: Flow Cytometry for Platelet Phenotyping at ISTH 2026
-
Jul 12, 2026, 06:45Brian O Mahony: Advancing Concizumab Therapy for Hemophilia With Inhibitors at ISTH 2026
-
Jul 12, 2026, 06:42PERT-Guided Patient Selection for Advanced Pulmonary Embolism Therapies
-
Jul 12, 2026, 06:12Precision in Antithrombotic Therapy at ISTH 2026 – The Lancet Haematology
-
Jul 11, 2026, 23:36Emmanuel J Favaloro: A Fresh Perspective on the Manual Tilt Tube Method for PT and INR Determination
-
Jul 11, 2026, 21:47Michelle Meyer: Working Together to Advance Stroke Prevention in Atrial Fibrillation
-
Jul 11, 2026, 21:44Timos Papagatsias: From Promising Concepts to Clinical Differentiation at ISTH 2026
-
Jul 11, 2026, 21:43Sharing New Research in Hemophilia at ISTH 2026 – Novo Nordisk Medical US